Business Context and Reporting Period
This Form 8-K filing by Marchex, Inc. (Marchex) is dated September 15, 2015. The report discloses the appointment of a new executive officer and details the associated compensatory arrangements.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on executive compensation terms.
- Base Salary: $300,000 annually.
- Target Bonus: Up to $350,000 annually based on performance measures.
- Equity Grants: 275,000 stock options and 225,000 shares of restricted stock.
- Severance: 6 months of base salary plus 50% of the target annual bonus upon termination without cause or resignation for good reason.
Material Changes
On September 15, 2015, Gary Nafus joined Marchex as Chief Revenue Officer. This represents a material change in the company's executive leadership team. Mr. Nafus previously served as Managing Director, Americas for Kenshoo Corporation and held various sales leadership roles at Oracle Corporation.
Outlook, Risks, and Unusual Items
Equity Vesting and Acceleration: The equity awards vest over four years (25% annually for restricted stock; 25% cliff vesting for options followed by quarterly vesting). Full acceleration of equity occurs upon a Change in Control followed by termination without cause, diminution in duties, or the 12-month anniversary of the Change in Control. Additionally, termination without cause or resignation for good reason triggers an additional 12 months of vesting on equity awards.
Risks: The filing outlines specific financial liabilities related to executive severance and equity acceleration in the event of a Change in Control or involuntary termination.
Investor Verification Checklist
- Verify the impact of the new Chief Revenue Officer's compensation package on future operating expenses.
- Confirm the dilution effect of the 500,000 total equity units (options and restricted stock) granted to Mr. Nafus.
- Review the specific definitions of "Change in Control," "Termination without Cause," and "Diminution in Duties" in the award agreements to understand potential future liabilities.
- Assess Mr. Nafus's track record at Kenshoo and Oracle relative to Marchex's strategic goals.